Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.

Misra N, Wines TF, Knopp CL, Hermann R, Bond L, Mitchell B, McGuire MA, Tinker JK.

Vaccine. 2018 Jun 7;36(24):3513-3521. doi: 10.1016/j.vaccine.2018.04.067. Epub 2018 May 5.

2.

Immunoproteomics to identify Staphylococcus aureus antigens expressed in bovine milk during mastitis.

Misra N, Pu X, Holt DN, McGuire MA, Tinker JK.

J Dairy Sci. 2018 Jul;101(7):6296-6309. doi: 10.3168/jds.2017-14040. Epub 2018 May 3.

3.

Expression, immunogenicity and variation of iron-regulated surface protein A from bovine isolates of Staphylococcus aureus.

Misra N, Wines TF, Knopp CL, McGuire MA, Tinker JK.

FEMS Microbiol Lett. 2017 May 1;364(9). doi: 10.1093/femsle/fnx082.

4.

Burrowing Owls, Pulex irritans, and Plague.

Belthoff JR, Bernhardt SA, Ball CL, Gregg M, Johnson DH, Ketterling R, Price E, Tinker JK.

Vector Borne Zoonotic Dis. 2015 Sep;15(9):556-64. doi: 10.1089/vbz.2015.1772. Epub 2015 Sep 14.

PMID:
26367482
5.

Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.

Tinker JK, Yan J, Knippel RJ, Panayiotou P, Cornell KA.

Toxins (Basel). 2014 Apr 22;6(4):1397-418. doi: 10.3390/toxins6041397.

6.

Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2/B chimera induces antigen-specific Th2-type responses in mice.

Arlian BM, Tinker JK.

Clin Vaccine Immunol. 2011 Sep;18(9):1543-51. doi: 10.1128/CVI.05146-11. Epub 2011 Jul 6.

7.

Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Tinker JK, Davis CT, Arlian BM.

Protein Expr Purif. 2010 Nov;74(1):16-23. doi: 10.1016/j.pep.2010.04.021. Epub 2010 May 11.

10.
12.

Supplemental Content

Loading ...
Support Center